IPSEN (EPA:IPN) | Finanzwire

Basculer en Français

8609	Companies
141631	Keywords
77524	Articles
75683	Press releases

Home
Companies
IPSEN

BRIEF

published on 04/04/2025 at 11:27, 7 days 2 hours ago

Share transfer: Parvus Asset Management crosses a threshold at IPSEN

Investment Management Threshold Crossing Shares And Voting Rights Ipsen SA Parvus Asset Management
BRIEF

published on 03/19/2025 at 07:05, 23 days 6 hours ago

Success of Ipsen's inaugural €500 million bond issue

Refinancing Institutional Investors Growth Bond Issue Investment Grade
PRESS RELEASE

published on 03/19/2025 at 07:00, 23 days 6 hours ago

Ipsen announces issuance of €500 million inaugural Rated Public Bond
Ipsen successfully completes inaugural €500 million Rated Public Bond issuance, supported by strong investor confidence and Investment Grade ratings from S&P and Moody's

Institutional Investors Financial Strategy Ipsen Investment Grade Ratings Rated Public Bond
BRIEF

published on 03/12/2025 at 07:33, 30 days 6 hours ago

Olivia Brown appointed to lead neurotoxin franchise at Ipsen

Innovation Appointment Ipsen Neurotoxins Olivia Brown
PRESS RELEASE

published on 03/12/2025 at 07:28, 30 days 6 hours ago

Ipsen appoints Olivia Brown as Executive Vice-President, Global Head of Neurotoxins
Ipsen appoints Olivia Brown as EVP, Global Head of Neurotoxins, leading strategic growth in therapeutic and aesthetic neurotoxins market. Olivia brings 20 years of pharmaceutical and aesthetics leadership experience

Innovation Ipsen Global Head Neurotoxins Olivia Brown
PRESS RELEASE

published on 02/21/2025 at 15:42, 1 month 17 days ago

Ipsen S.A. publishes its 2024 consolidated financial statements
BRIEF

published on 09/23/2024 at 11:01, 6 months 18 days ago

Parvus Asset Management crosses threshold in IPSEN SA

Euronext Paris Voting Rights Threshold Crossing Ipsen SA Parvus Asset Management
BRIEF

published on 09/16/2024 at 14:50, 6 months 24 days ago

Promising results for Cabometyx in advanced neuroendocrine tumors

Phase III Ipsen Neuroendocrine Tumors ESMO 2024 Cabometyx
PRESS RELEASE

published on 09/16/2024 at 14:45, 6 months 24 days ago

Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM

Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
BRIEF

published on 09/15/2024 at 14:50, 6 months 25 days ago

New analysis of the CONTACT-02 trial by Ipsen

Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx

Accesswire

Published on 04/11/2025 at 13:30, 11 minutes ago

Gratomic Announces Anticipated Default in Filing Financial Statements and Application for Management Cease Trade Order
Published on 04/11/2025 at 12:45, 56 minutes ago

April 11thMako Mining Reports Fourth Quarter and Full Year 2024 Financial Results, Including 2024 Adjusted EBITDA(1) of US$42.2 million and EPS of US$0.27 from 39,001 oz Gold Sold at an Average Price of US$2,397/oz
Published on 04/11/2025 at 02:40, 11 hours 1 minute ago

McFarlane Lake Announces Closing of Final Tranche of Upsized $1.3 Million Private Placement Offering
Published on 04/11/2025 at 02:00, 11 hours 41 minutes ago

Battery X Metals Announces Formation of Critical Battery Metals Exploration Subsidiary and Expansion of Quebec Exploration Portfolio with Acquisition of 39 Additional Mineral Claims
Published on 04/11/2025 at 00:00, 13 hours 41 minutes ago

Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research

View all ACCESSWIRE

EQS Group

Published on 04/11/2025 at 13:24, 16 minutes ago

Turkiye Garanti Bankasi A.S.: Brokerage Houses Warrants Initial Sale Prices
Published on 04/11/2025 at 13:06, 34 minutes ago

Turkiye Garanti Bankasi A.S.: Approval of the election of the Independent Audit Company by the General Assembly
Published on 04/11/2025 at 13:01, 39 minutes ago

Turkiye Garanti Bankasi A.S.: Announcement regarding the registration of the Ordinary General Shareholders’ Meeting
Published on 04/11/2025 at 12:22, 1 hour 18 minutes ago

Announcement of an audit order by BaFin
Published on 04/11/2025 at 11:23, 2 hours 18 minutes ago

PLANOPTIK AG: Annual Report 2024

Les Echos

Published on 04/10/2025 at 17:45, 19 hours 56 minutes ago

EURAZEO INVESTS IN EKOSCAN INTEGRITY, A LEADING GLOBAL PROVIDER OF ADVANCED NON-DESTRUCTIVE TESTING SOLUTIONS FOR CRITICAL INDUSTRIAL APPLICATIONS AND INFRASTRUCTURE
Published on 04/10/2025 at 17:27, 20 hours 13 minutes ago

2024 URD - Universal Registration Document
Published on 04/09/2025 at 18:59, 1 day 18 hours ago

Description of the 2025-2026 Share Buyback Program
Published on 04/09/2025 at 18:57, 1 day 18 hours ago

Minutes of the Combined General Meeting held on April 9, 2025
Published on 04/09/2025 at 17:45, 1 day 19 hours ago

COGELEC : 2024 full-year results and Q1 2025 revenue.

View all LES ECHOS COMFI WIRE